These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 19958217)

  • 1. Proteomic methodologies and their application in colorectal cancer research.
    Ikonomou G; Samiotaki M; Panayotou G
    Crit Rev Clin Lab Sci; 2009; 46(5-6):319-42. PubMed ID: 19958217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical proteomics and mass spectrometry profiling for cancer detection.
    Solassol J; Jacot W; Lhermitte L; Boulle N; Maudelonde T; Mangé A
    Expert Rev Proteomics; 2006 Jun; 3(3):311-20. PubMed ID: 16771703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of proteomic technologies for prostate cancer detection, prognosis, and tailored therapy.
    Fredolini C; Liotta LA; Petricoin EF
    Crit Rev Clin Lab Sci; 2010; 47(3):125-38. PubMed ID: 20858067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncoproteomics: current trends and future perspectives.
    Cho WC; Cheng CH
    Expert Rev Proteomics; 2007 Jun; 4(3):401-10. PubMed ID: 17552924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomic expression analysis of colorectal cancer by two-dimensional differential gel electrophoresis.
    Alfonso P; Núñez A; Madoz-Gurpide J; Lombardia L; Sánchez L; Casal JI
    Proteomics; 2005 Jul; 5(10):2602-11. PubMed ID: 15924290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mortalin is over-expressed by colorectal adenocarcinomas and correlates with poor survival.
    Dundas SR; Lawrie LC; Rooney PH; Murray GI
    J Pathol; 2005 Jan; 205(1):74-81. PubMed ID: 15532096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Present status of clinical proteomic analysis for the early detection and determination of therapeutic strategy in lung cancer.
    Hirano T; Kato H
    Ann Thorac Cardiovasc Surg; 2006 Feb; 12(1):4-9. PubMed ID: 16572067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategies for plasma proteomic profiling of cancers.
    Omenn GS
    Proteomics; 2006 Oct; 6(20):5662-73. PubMed ID: 16991194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The molecular make-up of a tumour: proteomics in cancer research.
    Kolch W; Mischak H; Pitt AR
    Clin Sci (Lond); 2005 May; 108(5):369-83. PubMed ID: 15831087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomic technologies and their application to pancreatic cancer.
    Vimalachandran D; Costello E
    Expert Rev Proteomics; 2004 Dec; 1(4):493-501. PubMed ID: 15966844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomarkers of chemotherapy resistance in breast cancer identified by proteomics: current status.
    Hodgkinson VC; Eagle GL; Drew PJ; Lind MJ; Cawkwell L
    Cancer Lett; 2010 Aug; 294(1):13-24. PubMed ID: 20176436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomic analysis of colorectal cancer: discovering novel biomarkers.
    Skandarajah AR; Moritz RL; Tjandra JJ; Simpson RJ
    Expert Rev Proteomics; 2005 Oct; 2(5):681-92. PubMed ID: 16209648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colorectal cancer proteomics, molecular characterization and biomarker discovery.
    Barderas R; Babel I; Casal JI
    Proteomics Clin Appl; 2010 Feb; 4(2):159-78. PubMed ID: 21137041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in clinical oncoproteomics.
    Jain KK
    J BUON; 2007 Sep; 12 Suppl 1():S31-8. PubMed ID: 17935275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advanced proteomic technologies for cancer biomarker discovery.
    Wong SC; Chan CM; Ma BB; Lam MY; Choi GC; Au TC; Chan AS; Chan AT
    Expert Rev Proteomics; 2009 Apr; 6(2):123-34. PubMed ID: 19385940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolving molecular classification by genomic and proteomic biomarkers in colorectal cancer: potential implications for the surgical oncologist.
    Søreide K; Nedrebø BS; Knapp JC; Glomsaker TB; Søreide JA; Kørner H
    Surg Oncol; 2009 Mar; 18(1):31-50. PubMed ID: 18672360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The potentials of MS-based subproteomic approaches in medical science: the case of lysosomes and breast cancer.
    Journet A; Ferro M
    Mass Spectrom Rev; 2004; 23(6):393-442. PubMed ID: 15290709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection and identification of heat shock protein 10 as a biomarker in colorectal cancer by protein profiling.
    Melle C; Bogumil R; Ernst G; Schimmel B; Bleul A; von Eggeling F
    Proteomics; 2006 Apr; 6(8):2600-8. PubMed ID: 16502466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteome analysis and tissue microarray for profiling protein markers associated with lymph node metastasis in colorectal cancer.
    Pei H; Zhu H; Zeng S; Li Y; Yang H; Shen L; Chen J; Zeng L; Fan J; Li X; Gong Y; Shen H
    J Proteome Res; 2007 Jul; 6(7):2495-501. PubMed ID: 17542627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ProteinChip Array analysis of microdissected colorectal carcinoma and associated tumor stroma shows specific protein bands in the 3.4 to 3.6 kDa range.
    Krieg RC; Fogt F; Braunschweig T; Herrmann PC; Wollscheidt V; Wellmann A
    Anticancer Res; 2004; 24(3a):1791-6. PubMed ID: 15274357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.